Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITDAEPS (Basic)EPS (Weighted Average and Diluted)Interest & Investment IncomeInterest ExpensesInterest ExpensesNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Achieve Life Sciences (ACHV) Shares Outstanding (Diluted Average) (2020 - 2026)

Achieve Life Sciences (ACHV) has disclosed Shares Outstanding (Diluted Average) for 10 consecutive years, with $53.4 million as the latest value for Q1 2026.

  • Quarterly Shares Outstanding (Diluted Average) rose 53.9% to $53.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $53.4 million through Mar 2026, up 53.9% year-over-year, with the annual reading at $43.6 million for FY2025, 35.93% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q1 2026 was $53.4 million at Achieve Life Sciences, up from $43.6 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $53.4 million in Q1 2026, with the low at $9.5 million in Q1 2022.
  • Average Shares Outstanding (Diluted Average) over 5 years is $26.9 million, with a median of $25.0 million recorded in 2024.
  • The sharpest move saw Shares Outstanding (Diluted Average) soared 120.05% in 2023, then increased 1.07% in 2025.
  • Achieve Life Sciences' Shares Outstanding (Diluted Average) stood at $10.6 million in 2022, then skyrocketed by 87.18% to $19.8 million in 2023, then skyrocketed by 61.75% to $32.1 million in 2024, then skyrocketed by 35.93% to $43.6 million in 2025, then grew by 22.45% to $53.4 million in 2026.
  • Per Business Quant, the three most recent readings for ACHV's Shares Outstanding (Diluted Average) are $53.4 million (Q1 2026), $43.6 million (Q4 2025), and $51.0 million (Q3 2025).